Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Kiltearn Partners LLP

Kiltearn Partners LLP raised its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 12.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,010,000 shares of the pharmacy operator’s stock after acquiring an additional 112,900 shares during the period. Walgreens Boots Alliance accounts for about 1.6% of Kiltearn Partners LLP’s holdings, making the stock its 25th biggest position. Kiltearn Partners LLP owned 0.12% of Walgreens Boots Alliance worth $9,423,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Walgreens Boots Alliance by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock valued at $805,506,000 after purchasing an additional 2,279,495 shares during the period. State Street Corp grew its stake in shares of Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after buying an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock worth $122,737,000 after buying an additional 2,185,950 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after buying an additional 817,762 shares during the period. Finally, Norges Bank acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at $58,241,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on WBA shares. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Royal Bank of Canada upped their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Finally, StockNews.com began coverage on shares of Walgreens Boots Alliance in a research note on Wednesday. They issued a “hold” rating for the company. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $11.16 on Friday. The firm has a fifty day moving average of $10.86 and a two-hundred day moving average of $9.88. The firm has a market cap of $9.64 billion, a P/E ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $22.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period last year, the firm earned $0.66 earnings per share. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.